Efficacy and Safety of Lesogaberan (AZD3355) in Chinese Patients With Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy: a Randomized Placebo-controlled Trial
Latest Information Update: 07 Jun 2018
At a glance
- Drugs Lesogaberan (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 11 Jul 2016 New trial record